Difference between revisions of "User:Bailey.Glen"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
 
(One intermediate revision by the same user not shown)
Line 10: Line 10:
 
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
−
|-|[[BRST5:Usual_ductal_hyperplasia|Usual ductal hyperplasia]]
+
|-
 +
 
 +
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered ]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma ]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Ganglioglioma|Ganglioglioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Gangliocytoma|Gangliocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive ]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 21: Line 452:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Columnar_cell_lesions,_including_flat_epithelial_atypia_|Columnar cell lesions, including flat epithelial atypia ]]
+
|[[CNS5:Subependymoma|Subependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 32: Line 463:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Atypical_ductal_hyperplasia|Atypical ductal hyperplasia]]
+
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
 
|Disease
 
|Disease
 
|
 
|
Line 43: Line 474:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Sclerosing_adenosis|Sclerosing adenosis]]
+
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
 
|Disease
 
|Disease
 
|
 
|
Line 54: Line 485:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Apocrine_adenosis_and_adenoma|Apocrine adenosis and adenoma]]
+
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 65: Line 496:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Microglandular_adenosis_|Microglandular adenosis ]]
+
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
 
|Disease
 
|Disease
 
|
 
|
Line 76: Line 507:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Radial_scar_/_complex_sclerosing_lesion_|Radial scar / complex sclerosing lesion ]]
+
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
 
|Disease
 
|Disease
 
|
 
|
Line 87: Line 518:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Tubular_adenoma_|Tubular adenoma ]]
+
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
 
|Disease
 
|Disease
 
|
 
|
Line 98: Line 529:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Lactating_adenoma_|Lactating adenoma ]]
+
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
 
|Disease
 
|Disease
 
|
 
|
Line 109: Line 540:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Ductal_adenoma|Ductal adenoma]]
+
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
 
|Disease
 
|Disease
 
|
 
|
Line 120: Line 551:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Pleomorphic_adenoma|Pleomorphic adenoma]]
+
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 131: Line 562:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Adenomyoepithelioma|Adenomyoepithelioma]]
+
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 142: Line 573:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Malignant_adenomyoepithelioma|Malignant adenomyoepithelioma]]
+
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
 
|Disease
 
|Disease
 
|
 
|
Line 153: Line 584:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Intraductal_papilloma|Intraductal papilloma]]
+
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
 
|Disease
 
|Disease
 
|
 
|
Line 164: Line 595:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Papillary_ductal_carcinoma_in_situ|Papillary ductal carcinoma in situ]]
+
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
 
|Disease
 
|Disease
 
|
 
|
Line 175: Line 606:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Encapsulated_papillary_carcinoma|Encapsulated papillary carcinoma]]
+
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
 
|Disease
 
|Disease
 
|
 
|
Line 186: Line 617:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Solid_papillary_carcinoma_(in_situ_and_invasive)|Solid papillary carcinoma (in situ and invasive)]]
+
|[[CNS5:Pineocytoma|Pineocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 197: Line 628:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Invasive_papillary_carcinoma|Invasive papillary carcinoma]]
+
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
 
|Disease
 
|Disease
 
|
 
|
Line 208: Line 639:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Atypical_lobular_hyperplasia_|Atypical lobular hyperplasia ]]
+
|[[CNS5:Pineoblastoma|Pineoblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 219: Line 650:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Lobular_carcinoma_in_situ|Lobular carcinoma in situ]]
+
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
 
|Disease
 
|Disease
 
|
 
|
Line 230: Line 661:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Ductal_carcinoma_in_situ_|Ductal carcinoma in situ ]]
+
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
 
|Disease
 
|Disease
 
|
 
|
Line 241: Line 672:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Invasive_breast_carcinoma:_General_overview|Invasive breast carcinoma: General overview]]
+
|[[CNS5:Schwannoma|Schwannoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 252: Line 683:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Invasive_breast_carcinoma_of_no_special_type|Invasive breast carcinoma of no special type]]
+
|[[CNS5:Neurofibroma|Neurofibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 263: Line 694:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Microinvasive_carcinoma|Microinvasive carcinoma]]
+
|[[CNS5:Perineurioma|Perineurioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 274: Line 705:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Invasive_lobular_carcinoma_|Invasive lobular carcinoma ]]
+
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
 
|Disease
 
|Disease
 
|
 
|
Line 285: Line 716:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Tubular_carcinoma|Tubular carcinoma]]
+
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 296: Line 727:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Cribriform_carcinoma|Cribriform carcinoma]]
+
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 307: Line 738:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Mucinous_carcinoma|Mucinous carcinoma]]
+
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
 
|Disease
 
|Disease
 
|
 
|
Line 318: Line 749:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Mucinous_cystadenocarcinoma|Mucinous cystadenocarcinoma]]
+
|[[CNS5:Meningioma|Meningioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 329: Line 760:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Invasive_micropapillary_carcinoma|Invasive micropapillary carcinoma]]
+
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 340: Line 771:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Carcinoma_with_apocrine_differentiation|Carcinoma with apocrine differentiation]]
+
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
 
|Disease
 
|Disease
 
|
 
|
Line 351: Line 782:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Metaplastic_carcinoma|Metaplastic carcinoma]]
+
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 362: Line 793:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Acinic_cell_carcinoma|Acinic cell carcinoma]]
+
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 373: Line 804:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]]
+
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
 
|Disease
 
|Disease
 
|
 
|
Line 384: Line 815:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Secretory_carcinoma_|Secretory carcinoma ]]
+
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 395: Line 826:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
+
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
 
|Disease
 
|Disease
 
|
 
|
Line 406: Line 837:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Polymorphous_adenocarcinoma|Polymorphous adenocarcinoma]]
+
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 417: Line 848:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Tall_cell_carcinoma_with_reversed_polarity|Tall cell carcinoma with reversed polarity]]
+
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 428: Line 859:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Neuroendocrine_tumour|Neuroendocrine tumour]]
+
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 439: Line 870:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Neuroendocrine_carcinoma|Neuroendocrine carcinoma]]
+
|[[CNS5:Chordoma|Chordoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 450: Line 881:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Hamartoma_|Hamartoma ]]
+
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 461: Line 892:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Fibroadenoma_|Fibroadenoma ]]
+
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 472: Line 903:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Phyllodes_tumour_|Phyllodes tumour ]]
+
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
 
|Disease
 
|Disease
 
|
 
|
Line 483: Line 914:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Syringomatous_tumour_|Syringomatous tumour ]]
+
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
 
|Disease
 
|Disease
 
|
 
|
Line 494: Line 925:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Nipple_adenoma_|Nipple adenoma ]]
+
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 505: Line 936:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Paget_disease_of_the_breast|Paget disease of the breast]]
+
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 516: Line 947:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Haemangioma|Haemangioma]]
+
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
 
|Disease
 
|Disease
 
|
 
|
Line 527: Line 958:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Angiomatosis|Angiomatosis]]
+
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
 
|Disease
 
|Disease
 
|
 
|
Line 538: Line 969:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Atypical_vascular_lesions_|Atypical vascular lesions ]]
+
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
 
|Disease
 
|Disease
 
|
 
|
Line 549: Line 980:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Postradiation_angiosarcoma_of_the_breast|Postradiation angiosarcoma of the breast]]
+
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
 
|Disease
 
|Disease
 
|
 
|
Line 560: Line 991:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Primary_angiosarcoma_of_the_breast|Primary angiosarcoma of the breast]]
+
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 
|Disease
 
|Disease
 
|
 
|
Line 571: Line 1,002:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Nodular_fasciitis|Nodular fasciitis]]
+
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 
|Disease
 
|Disease
 
|
 
|
Line 582: Line 1,013:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Myofibroblastoma|Myofibroblastoma]]
+
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 
|Disease
 
|Disease
 
|
 
|
Line 593: Line 1,024:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Desmoid_fibromatosis_|Desmoid fibromatosis ]]
+
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 604: Line 1,035:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Inflammatory_myofibroblastic_tumour_|Inflammatory myofibroblastic tumour ]]
+
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 615: Line 1,046:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Schwannoma_|Schwannoma ]]
+
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
 
|Disease
 
|Disease
 
|
 
|
Line 626: Line 1,057:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Neurofibroma_|Neurofibroma ]]
+
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 637: Line 1,068:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Granular_cell_tumour|Granular cell tumour]]
+
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 648: Line 1,079:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Leiomyoma|Leiomyoma]]
+
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 659: Line 1,090:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Leiomyosarcoma_|Leiomyosarcoma ]]
+
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 670: Line 1,101:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Lipoma_|Lipoma ]]
+
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 681: Line 1,112:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Angiolipoma_|Angiolipoma ]]
+
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
 
|Disease
 
|Disease
 
|
 
|
Line 692: Line 1,123:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Liposarcoma_|Liposarcoma ]]
+
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
 
|Disease
 
|Disease
 
|
 
|
Line 703: Line 1,134:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Pseudoangiomatous_stromal_hyperplasia|Pseudoangiomatous stromal hyperplasia]]
+
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
|Disease
 
|Disease
 
|
 
|
Line 714: Line 1,145:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Extranodal_marginal_zone_lymphoma_of_mucosa-associated_lymphoid_tissue_(MALT_lymphoma)|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)]]
+
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
 
|Disease
 
|Disease
 
|
 
|
Line 725: Line 1,156:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Follicular_lymphoma_|Follicular lymphoma ]]
+
|[[CNS5:Schwannomatosis|Schwannomatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 736: Line 1,167:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Diffuse_large_B-cell_lymphoma_|Diffuse large B-cell lymphoma ]]
+
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 747: Line 1,178:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Burkitt_lymphoma|Burkitt lymphoma]]
+
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 758: Line 1,189:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Breast_implant-associated_anaplastic_large_cell_lymphoma_|Breast implant-associated anaplastic large cell lymphoma ]]
+
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 769: Line 1,200:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Gynaecomastia|Gynaecomastia]]
+
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 780: Line 1,211:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Carcinoma_in_situ|Carcinoma in situ]]
+
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 791: Line 1,222:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Invasive_carcinoma|Invasive carcinoma]]
+
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
 
|Disease
 
|Disease
 
|
 
|
Line 802: Line 1,233:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Metastases_to_the_breast|Metastases to the breast]]
+
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 813: Line 1,244:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]]
+
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 824: Line 1,255:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Cowden_syndrome|Cowden syndrome]]
+
|[[CNS5:Carney_complex|Carney complex]]
 
|Disease
 
|Disease
 
|
 
|
Line 835: Line 1,266:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Ataxia-telangiectasia|Ataxia-telangiectasia]]
+
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 846: Line 1,277:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Li-Fraumeni_syndrome,_TP53-associated|Li-Fraumeni syndrome, TP53-associated]]
+
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
 
|Disease
 
|Disease
 
|
 
|
Line 857: Line 1,288:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Li-Fraumeni_syndrome,_CHEK2-associated|Li-Fraumeni syndrome, CHEK2-associated]]
+
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 868: Line 1,299:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:CDH1-associated_breast_cancer|CDH1-associated breast cancer]]
+
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 879: Line 1,310:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:PALB2-associated_cancers|PALB2-associated cancers]]
+
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 890: Line 1,321:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
+
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
 
|Disease
 
|Disease
 
|
 
|
Line 901: Line 1,332:
 
|
 
|
 
|-
 
|-
−
|[[BRST5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
+
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
 
|Disease
 
|Disease
 
|
 
|

Latest revision as of 12:28, 26 January 2024

WHO Classification of Tumours of the Central Nervous System (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Astrocytoma, IDH-mutant Disease
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted Disease
Glioblastoma, IDH-wildtype Disease
Diffuse astrocytoma, MYB- or MYBL1-altered Disease
Angiocentric glioma Disease
Polymorphous low-grade neuroepithelial tumour of the young Disease
Diffuse low-grade glioma, MAPK pathway-altered Disease
Diffuse midline glioma, H3 K27-altered Disease
Diffuse hemispheric glioma, H3 G34-mutant Disease
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype Disease
Infant-type hemispheric glioma Disease
Pilocytic astrocytoma Disease
High-grade astrocytoma with piloid features Disease
Pleomorphic xanthoastrocytoma Disease
Subependymal giant cell astrocytoma Disease
Chordoid glioma Disease
Astroblastoma, MN1-altered Disease
Ganglioglioma Disease
Gangliocytoma Disease
Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma Disease
Dysembryoplastic neuroepithelial tumour Disease
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters Disease
Papillary glioneuronal tumour Disease
Rosette-forming glioneuronal tumour Disease
Myxoid glioneuronal tumour Disease
Diffuse leptomeningeal glioneuronal tumour Disease
Multinodular and vacuolating neuronal tumour Disease
Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) Disease
Central neurocytoma Disease
Extraventricular neurocytoma Disease
Cerebellar liponeurocytoma Disease
Supratentorial ependymoma Disease
Supratentorial ependymoma, ZFTA fusion-positive Disease
Supratentorial ependymoma, YAP1 fusion-positive Disease
Posterior fossa ependymoma Disease
Posterior fossa group A (PFA) ependymoma Disease
Posterior fossa group B (PFB) ependymoma Disease
Spinal ependymoma Disease
Spinal ependymoma, MYCN-amplified Disease
Myxopapillary ependymoma Disease
Subependymoma Disease
Choroid plexus papilloma Disease
Atypical choroid plexus papilloma Disease
Choroid plexus carcinoma Disease
Medulloblastoma, WNT-activated Disease
Medulloblastoma, SHH-activated and TP53-wildtype Disease
Medulloblastoma, SHH-activated and TP53-mutant Disease
Medulloblastoma, non-WNT/non-SHH Disease
Medulloblastoma, histologically defined Disease
Atypical teratoid/rhabdoid tumour Disease
Cribriform neuroepithelial tumour Disease
Embryonal tumour with multilayered rosettes Disease
CNS neuroblastoma, FOXR2-activated Disease
CNS tumour with BCOR internal tandem duplication Disease
CNS embryonal tumour NEC/NOS Disease
Pineocytoma Disease
Pineal parenchymal tumour of intermediate differentiation Disease
Pineoblastoma Disease
Papillary tumour of the pineal region Disease
Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant Disease
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Hybrid nerve sheath tumours Disease
Malignant melanotic nerve sheath tumour Disease
Malignant peripheral nerve sheath tumour Disease
Cauda equina neuroendocrine tumour (previously paraganglioma) Disease
Meningioma Disease
Solitary fibrous tumour Disease
Haemangiomas and vascular malformations Disease
Haemangioblastoma Disease
Rhabdomyosarcoma Disease
Intracranial mesenchymal tumour, FET::CREB fusion-positive Disease
CIC-rearranged sarcoma Disease
Primary intracranial sarcoma, DICER1-mutant Disease
Ewing sarcoma Disease
Mesenchymal chondrosarcoma Disease
Chondrosarcoma Disease
Chordoma Disease
Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis Disease
Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma Disease
Primary diffuse large B-cell lymphoma of the CNS Disease
Immunodeficiency-associated CNS lymphomas Disease
Lymphomatoid granulomatosis Disease
Intravascular large B-cell lymphoma Disease
MALT lymphoma of the dura Disease
Other low-grade B-cell lymphomas of the CNS Disease
Anaplastic large cell lymphoma (ALK+/ALK−) Disease
T-cell and NK/T-cell lymphomas Disease
Erdheim-Chester disease Disease
Rosai-Dorfman disease Disease
Juvenile xanthogranuloma Disease
Langerhans cell histiocytosis Disease
Histiocytic sarcoma Disease
Germ cell tumours of the CNS Disease
Adamantinomatous craniopharyngioma Disease
Papillary craniopharyngioma Disease
Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma Disease
Pituitary adenoma / pituitary neuroendocrine tumour Disease
Pituitary blastoma Disease
Metastases to the brain and spinal cord parenchyma Disease
Metastases to the meninges Disease
Neurofibromatosis type 1 Disease
Neurofibromatosis type 2 Disease
Schwannomatosis Disease
Von Hippel-Lindau syndrome Disease
Tuberous sclerosis Disease
Li-Fraumeni syndrome Disease
Cowden syndrome Disease
Constitutional mismatch repair deficiency syndrome Disease
Familial adenomatous polyposis 1 Disease
Naevoid basal cell carcinoma syndrome Disease
Rhabdoid tumour predisposition syndrome Disease
Carney complex Disease
DICER1 syndrome Disease
Familial paraganglioma syndromes Disease
Melanoma-astrocytoma syndrome Disease
Familial retinoblastoma Disease
BAP1 tumour predisposition syndrome Disease
Fanconi anaemia Disease
ELP1-medulloblastoma syndrome Disease
Retrieved from "https://content.ccga.io/index.php?title=User:Bailey.Glen&oldid=14124"